ATE332366T1 - Dipeptidyl-peptidasen - Google Patents

Dipeptidyl-peptidasen

Info

Publication number
ATE332366T1
ATE332366T1 AT00962085T AT00962085T ATE332366T1 AT E332366 T1 ATE332366 T1 AT E332366T1 AT 00962085 T AT00962085 T AT 00962085T AT 00962085 T AT00962085 T AT 00962085T AT E332366 T1 ATE332366 T1 AT E332366T1
Authority
AT
Austria
Prior art keywords
nucleic acids
dipeptidyl peptidases
dipeptidyl peptidase
dpp8
dppiv
Prior art date
Application number
AT00962085T
Other languages
English (en)
Inventor
Catherine Anne Abbott
Mark Douglas Gorell
Original Assignee
Univ Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPQ2762A external-priority patent/AUPQ276299A0/en
Priority claimed from AUPQ5709A external-priority patent/AUPQ570900A0/en
Application filed by Univ Sydney filed Critical Univ Sydney
Application granted granted Critical
Publication of ATE332366T1 publication Critical patent/ATE332366T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT00962085T 1999-09-10 2000-09-11 Dipeptidyl-peptidasen ATE332366T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ2762A AUPQ276299A0 (en) 1999-09-10 1999-09-10 Peptide and nucleic acid molecule
AUPQ5709A AUPQ570900A0 (en) 2000-02-18 2000-02-18 Peptide and nucleic acid molecule

Publications (1)

Publication Number Publication Date
ATE332366T1 true ATE332366T1 (de) 2006-07-15

Family

ID=25646142

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00962085T ATE332366T1 (de) 1999-09-10 2000-09-11 Dipeptidyl-peptidasen

Country Status (9)

Country Link
US (2) US6881564B1 (de)
EP (1) EP1214344B1 (de)
JP (1) JP4748908B2 (de)
AT (1) ATE332366T1 (de)
CA (1) CA2384135A1 (de)
DE (1) DE60029230T2 (de)
DK (1) DK1214344T3 (de)
ES (1) ES2269178T3 (de)
WO (1) WO2001019866A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1163594C (zh) * 1997-09-29 2004-08-25 尖端医疗有限公司 体外造血细胞的刺激
US6979697B1 (en) * 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
ATE332366T1 (de) * 1999-09-10 2006-07-15 Univ Sydney Dipeptidyl-peptidasen
EP1280922A2 (de) * 2000-04-18 2003-02-05 Millennium Pharmaceuticals, Inc. 21953, ein mitglied der menschlichen prolyl oligopeptidase familie, und verwendungen davon
US20040047853A1 (en) * 2000-06-09 2004-03-11 Dahl Soren W Purified proenzyme of dipeptidyl peptidase i (pro-dppi)
CZ20031301A3 (cs) 2000-10-12 2003-10-15 Ferring Bv Izolovaná nukleová kyselina, polypeptid, expresní vektor a protilátka
AUPR107800A0 (en) * 2000-10-27 2000-11-23 University Of Sydney, The Peptide and nucleic acid molecule ii
DE10100053A1 (de) * 2001-01-02 2002-08-22 Keyneurotek Ag I G Verwendung von Enzyminhibitoren der Dipeptidylpeptidase IV sowie der Aminopeptidase N und pharmazeutischen Zubereitungen daraus zur Prävention und/oder Therapie Ischämie-bedingter akuter und chronischer neurodegenerativer Prozesse und Erkrankungen
WO2002066627A1 (en) * 2001-02-16 2002-08-29 Bayer Aktiengesellschaft Regulation of human dipeptidyl peptidase 8
DE10150203A1 (de) 2001-10-12 2003-04-17 Probiodrug Ag Peptidylketone als Inhibitoren der DPIV
DE60222667T2 (de) 2001-06-27 2008-07-17 Smithkline Beecham Corp. Fluorpyrrolidine als dipeptidylpeptidaseinhibitoren
AU2002357767C1 (en) * 2001-11-26 2009-03-19 Trustees Of Tufts College Peptidomimetic inhibitors of post-proline cleaving enzymes
EP1528931B1 (de) 2002-08-09 2008-05-07 Prosidion Ltd. Dipeptidyl peptidase iv inhibitoren zur senkung der chronische gewichtszunahme
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
WO2005106021A1 (en) * 2004-04-28 2005-11-10 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 8 (dpp8)
US20080166357A1 (en) * 2004-05-11 2008-07-10 Stefan Golz Diagnostics and Therapeutics for Diseases Associated with Dipeptidyl-Peptidase 6 (Dpp6)
US7687638B2 (en) 2004-06-04 2010-03-30 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
WO2006019965A2 (en) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US20060063719A1 (en) * 2004-09-21 2006-03-23 Point Therapeutics, Inc. Methods for treating diabetes
PT1942898E (pt) 2005-09-14 2011-12-20 Takeda Pharmaceutical Inibidores da dipeptidilpeptidase para o tratamento da diabetes
JP5122462B2 (ja) 2005-09-16 2013-01-16 武田薬品工業株式会社 ジペプチジルペプチダーゼ阻害剤
EP1971614A1 (de) 2005-11-14 2008-09-24 Probiodrug AG Cyclopropylkondensierte pyrrolidinderivate als dipeptidylpeptidase-iv-inhibitoren
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
CA2649209A1 (en) 2006-04-12 2007-10-18 Probiodrug Ag Enzyme inhibitors
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US11473073B2 (en) * 2015-06-26 2022-10-18 Dupont Nutrition Biosciences Aps Aminopeptidases for protein hydrolyzates
WO2018129497A1 (en) 2017-01-09 2018-07-12 Bioxcel Therapeutics, Inc. Predictive and diagnostic methods for prostate cancer
DE102018107224A1 (de) 2018-02-21 2019-08-22 Immatics Biotechnologies Gmbh Peptide und Kombinationen von Peptiden nicht-kanonischen Ursprungs zur Verwendung in der Immuntherapie gegen verschiedene Krebsarten

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977085A (en) * 1984-02-29 1990-12-11 The Board Of Regents Of The Univ. Of California Cloning and expression of yeast STE13 and Dpp2 genes encoding dipeptidyl aminopeptidase A and B
US5231126A (en) * 1985-04-01 1993-07-27 Shi Guan Yi Beta-crystalline form of isotactic polypropylene and method for forming the same
EP0958313B1 (de) * 1997-02-07 2002-09-25 ExxonMobil Chemical Patents Inc. Thermoplastische,elastomere zusammensetzungen aus verzweigten olefincopolymeren
US20040132158A1 (en) * 1999-01-11 2004-07-08 Incyte Corporation Human peptidases
ATE332366T1 (de) * 1999-09-10 2006-07-15 Univ Sydney Dipeptidyl-peptidasen
CN1333032C (zh) * 1999-12-22 2007-08-22 埃克森美孚化学专利公司 聚丙烯基粘合剂组合物
US20030198953A1 (en) * 2000-03-30 2003-10-23 Spytek Kimberly A. Novel proteins and nucleic acids encoding same
CZ20031301A3 (cs) * 2000-10-12 2003-10-15 Ferring Bv Izolovaná nukleová kyselina, polypeptid, expresní vektor a protilátka
US6774069B2 (en) * 2000-12-29 2004-08-10 Kimberly-Clark Worldwide, Inc. Hot-melt adhesive for non-woven elastic composite bonding
US20020123538A1 (en) * 2000-12-29 2002-09-05 Peiguang Zhou Hot-melt adhesive based on blend of amorphous and crystalline polymers for multilayer bonding
CA2499951C (en) * 2002-10-15 2013-05-28 Peijun Jiang Multiple catalyst system for olefin polymerization and polymers produced therefrom
US7223822B2 (en) * 2002-10-15 2007-05-29 Exxonmobil Chemical Patents Inc. Multiple catalyst and reactor system for olefin polymerization and polymers produced therefrom
US7550528B2 (en) * 2002-10-15 2009-06-23 Exxonmobil Chemical Patents Inc. Functionalized olefin polymers
US7700707B2 (en) * 2002-10-15 2010-04-20 Exxonmobil Chemical Patents Inc. Polyolefin adhesive compositions and articles made therefrom

Also Published As

Publication number Publication date
JP4748908B2 (ja) 2011-08-17
US7148338B2 (en) 2006-12-12
DK1214344T3 (da) 2006-11-06
EP1214344B1 (de) 2006-07-05
EP1214344A1 (de) 2002-06-19
CA2384135A1 (en) 2001-03-22
US6881564B1 (en) 2005-04-19
ES2269178T3 (es) 2007-04-01
EP1214344A4 (de) 2004-03-10
DE60029230T2 (de) 2007-06-06
WO2001019866A1 (en) 2001-03-22
JP2003509041A (ja) 2003-03-11
DE60029230D1 (de) 2006-08-17
US20040191826A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
ATE332366T1 (de) Dipeptidyl-peptidasen
PL369741A1 (en) Immunocytokines with modulated selectivity
HN1998000132A (es) Combinaciones terapeuticas
DK1242452T3 (da) Kimære natriuretiske peptider
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
NO2013009I1 (no) Alipogen tiparvovec
BRPI0412845A (pt) herpes-vìrus, uso de um vìrus, composição farmacêutica, e, método de tratamento de um tumor em um indivìduo em necessidade do mesmo
NO20020348L (no) Peptid acceptor ligeringsmetoder
SI2345671T1 (sl) Optimizirane Fc-variante in postopki za njihovo izdelavo
EP1381280A4 (de) Virusvektoren und ihre verwendung bei therapeutischen methoden
DE69840230D1 (de) Polypeptide mit prolyldipeptidylaminopeptidase-aktivität und dafür kodierende nukleinsäuren
CY1112957T1 (el) Μη νευροτοξικοι παραγοντες, οι οποιοι ενεργοποιουν το πλασμινογονο για τη θεραπευτικη αγωγη εγκεφαλικου επεισοδιου
CA95793S (en) Paving stone
TR199800445A3 (tr) cdc25B geni yükselticisi, hazirlanisi ve kullanimi.
DE60139544D1 (de) Veränderte, fluoreszierende proteine
ATE309356T1 (de) Konstruierte fluoreszenzproteine mit langen wellenlängen
WO2001075068A3 (en) Secreted proteins and polynucleotides encoding them
NO20003146D0 (no) Ketonperoksyd-derivater, deres fremstilling og anvendelse
BR0111692A (pt) Processo para preparação de polipeptìdeo il-18 fisiologicamente ativo
ATE187890T1 (de) Ligandgerichtete enzyme-prodrug therapie
TR200103219T2 (tr) Nöropatik ağrının iyileştirilmesinde kullanım için aroil aminoasil piroller
DE69930370D1 (de) Testisspezifische, menschliche proteinase, svph1-8
DK1196607T3 (da) Antibakterielt chlamysin B-protein, gen kodende derfor samt ekspressionssystem
AU2003227049A1 (en) Viral mutants, manipulated in the furin cleavage sites of glycoproteins
DK0980379T3 (da) Chimære oligonucleotider og deres anvendelse

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1214344

Country of ref document: EP